TREATMENT OF PATIENTS DIAGNOSED WITH PANCREATIC DUCTAL ADENOCARCINOMA USING USING MONOCLONAL ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20180221478A1
SERIAL NO

15748173

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to the field of immunotherapy of cancer, in particular pancreatic ductal adenocarcinoma (PDAC). Means and methods for treatment of a population of PDAC patients suffering from PDAC tumours which express wildtype KRAS, HRAS or NRAS are disclosed. The claimed antibody is Nimotuzumab. The pancreatic cancer preferably does not contain KRAS mutations at position 12, 16, 61, 154.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INNOCIMAB PTE LTDWCEGA TOWER # 14-78 21 BUKIT BATOK SINGAPORE 659065 SINGAPORE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BACH, Ferdinand Wedel, DE 3 0
BEHRINGER, Dirk M Bochum, DE 2 0
DE, DOSSO Sara Bellinzona, CH 1 0
DOMMACH, Markus Duesseldorf, DE 1 0
EBERT, Matthias P Munich, DE 1 0
GOKER, Erdem Izmir, TR 1 0
HOFHEINZ, Ralf Mannheim, DE 1 0
ILYAS, Rikrik Asiyah Singapore, SG 2 0
IZNAGA, ESCOBAR Normando E Singapore, SG 2 0
KERKHOFF, Andrea Muenster, DE 1 0
KNEBA, Michael Schleswig-Holstein Kiel, DE 5 114
OVERKAMP, Friedrich Recklinghausen, DE 1 0
REUTER, Dirk Wedel, DE 9 301
ROHRBERG, Robert Halle, DE 1 0
SCHLEGEL, Frank Eschweiler, DE 1 0
SCHMIDT, Wolfgang E Bochum, DE 1 0
SCHULTHEIS, Beate Herne, DE 1 0
SIVEKE, Jens Munich, DE 1 0
STEINMETZ, Tilman Cologne, DE 1 0
STRUMBERG, Dirk Herne, DE 3 0
YALCIN, Suayib Ankara, TR 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation